ASHLEY JAEGER: Open Payments
NPI 1275313215 · HOLMDEL, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,339 in 73 payments from 21 companies in 2025. Trend: 2023 $14 · 2024 $802 · 2025 $1,339
Food & beverage: $1,339
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 10 | $220 |
| Novo Nordisk Inc | 10 | $168 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 9 | $154 |
| Phathom Pharmaceuticals, Inc. | 8 | $113 |
| GlaxoSmithKline, LLC. | 5 | $83 |
| VERTEX PHARMACEUTICALS INCORPORATED | 4 | $69 |
| ABBVIE INC. | 4 | $65 |
| Amgen Inc. | 3 | $53 |
| PFIZER INC. | 3 | $52 |
| Merck Sharp & Dohme LLC | 3 | $51 |
Products named: FARXIGA, XIFAXAN, VOQUEZNA, TRELEGY ELLIPTA, Ozempic, JOURNAVX, AIRSUPRA, VERQUVO.
Industry payments across NJ — which companies pay providers there.
